Corcept Therapeutics Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.03M1.01M-0.03M81.32M159.20M251.25M306.49M353.87M365.98M401.86M482.38M675.04M
Cost of Revenue 2.06M3.55M5.21M5.50M5.58M5.28M5.38M6.48M10.88M
Gross Profit 0.03M1.01M-0.03M79.26M155.65M246.03M300.98M348.29M360.70M396.47M475.89M664.16M
Operating items
Research & Development 0.26M18.95M21.00M23.84M40.38M75.25M89.02M114.76M113.86M130.99M184.35M246.89M
Selling, General & Administrative 1.55M8.49M11.33M45.24M62.42M81.29M100.36M105.33M122.36M152.85M184.26M280.32M
Restructuring Costs 14.00M
Other Operating Expenses 18.46M2.06M3.55M5.21M5.50M5.58M5.28M14.00M6.48M10.88M
Operating Expenses 20.28M27.44M32.33M71.14M106.35M161.75M194.88M225.67M241.50M289.22M375.09M538.09M
Operating Income -20.25M-27.44M-32.33M10.18M52.85M89.50M111.61M128.20M124.48M112.63M107.28M136.95M
EBIT -20.25M-27.44M-32.33M10.18M52.85M89.50M111.61M128.20M124.48M112.63M107.28M136.95M
Non-operating items
Interest & Investment Income 0.10M1.50M0.00M-2.04M-0.05M2.66M5.07M3.40M0.53M3.56M
Non Operating Income 0.53M3.56M17.27M24.54M
Net income details
EBT -20.13M-25.97M-32.35M8.14M52.81M92.15M116.68M131.60M125.01M116.19M124.56M161.49M
Tax Provisions -76.32M16.74M22.50M25.59M12.49M14.77M18.42M20.28M
Profit After Tax -20.17M-25.97M-32.35M8.14M129.12M75.41M94.18M106.01M112.51M101.42M106.14M141.21M
Income from Continuing Operations -20.13M-25.97M-32.35M8.14M129.12M75.41M94.18M106.01M112.51M101.42M106.14M141.21M
Consolidated Net Income -20.13M-25.97M-32.35M8.14M129.12M75.41M94.18M106.01M112.51M101.42M106.14M141.21M
Income towards Parent Company -20.13M-25.97M-32.35M8.14M129.12M75.41M94.18M106.01M112.51M101.42M106.14M141.21M
Net Income towards Common Stockholders -20.13M-25.97M-32.35M8.14M129.12M75.41M94.18M106.01M112.51M101.29M105.50M139.73M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
EPS (Weighted Average and Diluted) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Shares Outstanding (Weighted Average) 62.47M72.38M84.23M99.81M99.81M101.19M108.78M111.03M114.12M115.47M114.28M116.17M115.45M107.65M103.08M104.78M
Shares Outstanding (Diluted Average) 116.14M124.52M126.69M122.57M124.19M125.96M115.97M111.74M113.48M
EBITDA -20.25M-27.44M-32.33M8.14M129.05M75.42M94.51M106.17M111.87M112.63M107.28M136.95M
Tax Rate 18.17%19.28%19.45%9.99%12.71%14.79%12.56%